# Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac in Healthy Infants in Vietnam

> **NCT04596696** · PHASE3 · COMPLETED · sponsor: **Bharat Biotech International Limited** · enrollment: 360 (actual)

## Conditions studied

- Rotavirus Gastroenteritis

## Interventions

- **BIOLOGICAL:** Rotavac

## Key facts

- **NCT ID:** NCT04596696
- **Lead sponsor:** Bharat Biotech International Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-20
- **Primary completion:** 2018-12-30
- **Final completion:** 2019-06-30
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2020-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04596696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04596696, "Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac in Healthy Infants in Vietnam". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04596696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*